Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 10 of 82 for:    abp 798

Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00695786
Recruitment Status : Active, not recruiting
First Posted : June 12, 2008
Last Update Posted : January 2, 2020
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center